|
J Biol Chem, Vol. 273, Issue 23, 14261-14268, June 5, 1998
Cyclic Nucleotide Regulation of Type-1 Plasminogen
Activator-Inhibitor mRNA Stability in Rat Hepatoma Cells
IDENTIFICATION OF cis-ACTING SEQUENCES
Joanne H.
Heaton,
Maribeth
Tillmann-Bogush,
Nancy S.
Leff, and
Thomas D.
Gelehrter
From the Departments of Human Genetics and Internal Medicine,
University of Michigan Medical School,
Ann Arbor, Michigan 48109-0618
Type-1 plasminogen activator-inhibitor (PAI-1) is
a major physiologic inhibitor of plasminogen activation. Incubation of
HTC rat hepatoma cells with the cyclic nucleotide analogue,
8-bromo-cAMP, causes a dramatic increase in tissue-type plasminogen
activator activity secondary to a 90% decrease in PAI-1 mRNA.
Although 8-bromo-cAMP causes a modest decrease in PAI-1 transcription,
regulation is primarily the result of a 3-fold increase in the rate of
PAI-1 mRNA degradation. To determine the cis-acting
sequences required for cyclic nucleotide regulation, we have stably
transfected HTC cells with chimeric genes containing sequences from the
rat PAI-1 cDNA and the mouse -globin gene and examined the
effect of cyclic nucleotides on the decay rate of these transcripts.
The mRNA transcribed from the -globin gene is stable and not
cyclic nucleotide-regulated, whereas the transcript from a construct
containing the -globin coding region and the PAI-1 3'-untranslated
region (UTR) is destabilized in the presence of 8-bromo-cAMP,
suggesting that this response is mediated by sequences in the PAI-1
3'-UTR. Analyses by deletion of sequences from this chimeric construct
indicate that, whereas more than one region of the PAI-1 3'-UTR can
confer cyclic nucleotide responsiveness, the 3'-most 134-nucleotide
sequence alone is sufficient to do so. Insertion of PAI-1 sequences
within the -globin 3'-UTR confirms that the 3'-most 134 nucleotides
of PAI-1 mRNA can confer cyclic nucleotide regulation of stability
on a heterologous transcript, suggesting that this sequence may play a
major role in hormonal regulation of PAI-1 mRNA stability.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Angenstein, A. M. Evans, S.-C. Ling, R. E. Settlage, S. Ficarro, F. A. Carrero-Martinez, J. Shabanowitz, D. F. Hunt, and W. T. Greenough
Proteomic Characterization of Messenger Ribonucleoprotein Complexes Bound to Nontranslated or Translated Poly(A) mRNAs in the Rat Cerebral Cortex
J. Biol. Chem.,
February 25, 2005;
280(8):
6496 - 6503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. Smith, S. R. Coats, H. Qin, M. S. Petrie, J. W. Covington, M. Su, M. Eren, and D. E. Vaughan
Differential and Opposing Regulation of PAI-1 Promoter Activity by Estrogen Receptor {alpha} and Estrogen Receptor {beta} in Endothelial Cells
Circ. Res.,
August 6, 2004;
95(3):
269 - 275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Shetty, K. Bdeir, D. B. Cines, and S. Idell
Induction of Plasminogen Activator Inhibitor-1 by Urokinase in Lung Epithelial Cells
J. Biol. Chem.,
May 9, 2003;
278(20):
18124 - 18131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Zierold, J. A. Mings, and H. F. DeLuca
Parathyroid hormone regulates 25-hydroxyvitamin D3-24-hydroxylase mRNA by altering its stability
PNAS,
October 31, 2001;
(2001)
241516798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Takeda, T. Ichiki, T. Tokunou, N. Iino, S. Fujii, A. Kitabatake, H. Shimokawa, and A. Takeshita
Critical Role of Rho-Kinase and MEK/ERK Pathways for Angiotensin II-Induced Plasminogen Activator Inhibitor Type-1 Gene Expression
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2001;
21(5):
868 - 873.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Xu and T. J. Murphy
Reconstitution of Angiotensin Receptor mRNA Down-regulation in Vascular Smooth Muscle. POST-TRANSCRIPTIONAL CONTROL BY PROTEIN KINASE A BUT NOT MITOGENIC SIGNALING DIRECTED BY THE 5'-UNTRANSLATED REGION
J. Biol. Chem.,
March 10, 2000;
275(11):
7604 - 7611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Seki, A. M. Healy, D. S. Fletcher, T. Noguchi, and T. D. Gelehrter
IL-1beta mediates induction of hepatic type 1 plasminogen activator inhibitor in response to local tissue injury
Am J Physiol Gastrointest Liver Physiol,
October 1, 1999;
277(4):
G801 - G809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tillmann-Bogush, J. H. Heaton, and T. D. Gelehrter
Cyclic Nucleotide Regulation of PAI-1 mRNA Stability. IDENTIFICATION OF CYTOSOLIC PROTEINS THAT INTERACT WITH AN A-RICH SEQUENCE
J. Biol. Chem.,
January 8, 1999;
274(2):
1172 - 1179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Heaton, W. M. Dlakic, M. Dlakic, and T. D. Gelehrter
Identification and cDNA Cloning of a Novel RNA-binding Protein That Interacts with the Cyclic Nucleotide-responsive Sequence in the Type-1 Plasminogen Activator Inhibitor mRNA
J. Biol. Chem.,
January 26, 2001;
276(5):
3341 - 3347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Zierold, J. A. Mings, and H. F. DeLuca
Parathyroid hormone regulates 25-hydroxyvitamin D3-24-hydroxylase mRNA by altering its stability
PNAS,
November 20, 2001;
98(24):
13572 - 13576.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|